President Trump nominates health policy veteran to FDA post

WASHINGTON — President Trump on Friday announced his intent to nominate former FDA deputy commissioner Scott Gottlieb to be the new commissioner of Food and Drugs at the Department of Health and Human Services.



The appointment is subject to Senate confirmation.



“Scott’s impressive career as a physician and policy expert demonstrates a career-long commitment to public health,” stated AEI president Arthur Brooks. “He understands the FDA’s vital role in assuring public safety while allowing patients to benefit from cutting-edge medical discoveries. Americans are lucky that Scott will be serving our country in this role.”



Gottlieb is currently a clinical assistant professor at New York University School of Medicine and advises the U.S. Department of Health and Human Services as a member of the Federal Health IT Policy Committee. He was a practicing physician and hospitalist for many years and has advised health care entrepreneurs.



He had served as a senior adviser at the Centers for Medicare and Medicaid Services during the Bush years.



In 2005, Gottleib was named deputy commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration. He was awarded the Visionary in Medicine Award by the Sarcoma Foundation of America in May 2007, the Food and Drug Administration’s Special Recognition Award in January 2007 and the Centers for Medicaid and Medicare Services Administrator’s Citation in June 2004.



Gottlieb earned a Bachelor of Arts in Economics from Wesleyan University in 1994 and also holds a Doctor of Medicine from the Mount Sinai School of Medicine in 1999.